DELLA CORTE, Carminia Maria
 Distribuzione geografica
Continente #
EU - Europa 44
AS - Asia 25
NA - Nord America 24
Totale 93
Nazione #
US - Stati Uniti d'America 24
IE - Irlanda 19
IT - Italia 15
CN - Cina 10
VN - Vietnam 8
DE - Germania 2
FR - Francia 2
NL - Olanda 2
RU - Federazione Russa 2
SY - Repubblica araba siriana 2
TR - Turchia 2
ID - Indonesia 1
KR - Corea 1
MK - Macedonia 1
MV - Maldive 1
UA - Ucraina 1
Totale 93
Città #
Dublin 19
Ashburn 11
Dong Ket 8
Wuhan 4
Clarks Summit 3
Altavilla Silentina 2
Bremen 2
Caserta 2
Changsha 2
Chicago 2
Council Bluffs 2
Naples 2
Rome 2
Amsterdam 1
Ann Arbor 1
Beijing 1
Bitola 1
Bologna 1
Chongqing 1
Denver 1
Goyang-si 1
Guangzhou 1
Houston 1
Los Angeles 1
Male 1
Palembang 1
Parma 1
Portici 1
Shanghai 1
Totale 77
Nome #
Mechanisms of resistance to EGFR-targeted drugs: lung cancer, file dfd1c04b-5e84-0799-e053-6605fe0a8ddb 30
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells, file dfd1c04b-e232-0799-e053-6605fe0a8ddb 30
Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence., file dfd1c04b-607b-0799-e053-6605fe0a8ddb 16
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets, file dfd1c04b-eb6a-0799-e053-6605fe0a8ddb 13
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines, file dfd1c04a-60a4-0799-e053-6605fe0a8ddb 2
Feasibility of next-generation sequencing in clinical practice: Results of a pilot study in the Department of Precision Medicine at the University of Campania ' Luigi Vanvitelli', file dfd1c04d-2d52-0799-e053-6605fe0a8ddb 1
Hypothalamic–pituitary autoimmunity in patients treated with anti-pd-1 and anti-pd-l1 antibodies, file dfd1c04d-ddbd-0799-e053-6605fe0a8ddb 1
Totale 93
Categoria #
all - tutte 461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 2 0
2019/20208 0 1 0 0 2 1 0 2 1 0 1 0
2020/202120 0 0 0 2 2 4 2 0 1 0 0 9
2021/20225 0 0 0 0 0 0 3 0 0 0 1 1
2022/202333 2 0 1 0 2 2 2 0 19 0 3 2
2023/202424 1 0 6 4 2 1 9 0 1 0 0 0
Totale 93